Q3 2019 Investor Conference Call

Wednesday, October 30, 2019
Start at approx. 2:00 p.m. CET (1:00 p.m. UTC)


Investor News October 30, 2019

Third quarter of 2019

Bayer: Encouraging business performance across all divisions - agreements signed to divest Currenta and Animal Health

Group sales increase by 5.4 percent (Fx & portfolio adj.) to 9.830 billion euros / EBITDA before special items advances by 7.5 percent to 2.291 billion euros / Crop Science reports higher sales and substantial earnings growth / Pharmaceuticals increases sales - earnings decline due to one-time income in prior year / Consumer Health posts growth in sales (Fx & portfolio adj.) and earnings / Net income declines by 63.9 percent to 1.036 billion euros - substantial divestment gain included in prior year / Core earnings per share up by 6.4 percent to 1.16 euros / Group outlook confirmed and aligned to continuing operations?MORE

?


?

Baumann_125px_201604_a765ed_05.jpg

Werner Baumann
CEO of Bayer AG

Audio recording of the investor conference call?

?

Audio file

You can also play the audio recording on your mobile device.?

?

Nickl_125px_20180725_fd2aad_03.png

Wolfgang Nickl
CFO of Bayer AG

Presentation charts

Quarterly Statement Third Quarter 2019

Q3 2019 Analyst and Investor Briefing

Transcript

Q3 2019 All in One Package for Investors and Analysts

Restatements of Q1-Q4 2018 and Q1-Q2 2019 due to presentation of Animal Health & Currenta as discontinued operations

?

?